483 related articles for article (PubMed ID: 20152959)
1. Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery.
Maca SM; Amon M; Findl O; Kahraman G; Barisani-Asenbauer T
Am J Ophthalmol; 2010 May; 149(5):777-84. PubMed ID: 20152959
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery.
Flach AJ; Dolan BJ; Donahue ME; Faktorovich EG; Gonzalez GA
Ophthalmology; 1998 Sep; 105(9):1775-9. PubMed ID: 9754191
[TBL] [Abstract][Full Text] [Related]
3. Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation.
Flach AJ; Dolan BJ
Trans Am Ophthalmol Soc; 2000; 98():101-5; discussion 105-7. PubMed ID: 11190013
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy and safety of two formulations of diclofenac sodium 0.1% eyedrops in controlling postoperative inflammation after cataract surgery.
Bodaghi B; Weber ME; Arnoux YV; Jaulerry SD; Le Hoang P; Colin J
Eur J Ophthalmol; 2005; 15(6):702-11. PubMed ID: 16329054
[TBL] [Abstract][Full Text] [Related]
5. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells.
el-Harazi SM; Ruiz RS; Feldman RM; Villanueva G; Chuang AZ
Ophthalmic Surg Lasers; 1998 Jul; 29(7):539-44. PubMed ID: 9674003
[TBL] [Abstract][Full Text] [Related]
6. [Minimally inflammatory cataract surgery].
Hessemer V; Schmidt KG; Schartner H
Klin Monbl Augenheilkd; 1996 Dec; 209(6):331-9. PubMed ID: 9091708
[TBL] [Abstract][Full Text] [Related]
7. Twice-daily, preservative-free ketorolac 0.45% for treatment of inflammation and pain after cataract surgery.
Donnenfeld ED; Nichamin LD; Hardten DR; Raizman MB; Trattler W; Rajpal RK; Alpern LM; Felix C; Bradford RR; Villanueva L; Hollander DA; Schiffman RM
Am J Ophthalmol; 2011 Mar; 151(3):420-6.e1. PubMed ID: 21145532
[TBL] [Abstract][Full Text] [Related]
8. A comparison of preservative-free diclofenac and preserved diclofenac eye drops after cataract surgery in patients with diabetic retinopathy.
Yasuda K; Miyazawa A; Shimura M
J Ocul Pharmacol Ther; 2012 Jun; 28(3):283-9. PubMed ID: 22149554
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ocular tolerability between preserved and preservative-free diclofenac sodium drops.
Moisseiev E; Varssano D
J Ocul Pharmacol Ther; 2011 Aug; 27(4):333-7. PubMed ID: 21702687
[TBL] [Abstract][Full Text] [Related]
10. Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1%.
Asano S; Miyake K; Ota I; Sugita G; Kimura W; Sakka Y; Yabe N
J Cataract Refract Surg; 2008 Jan; 34(1):57-63. PubMed ID: 18165082
[TBL] [Abstract][Full Text] [Related]
11. [Anti-inflammatory effects and aqueous humor concentration of various nonsteroidal anti-inflammatory drugs in extracapsular cataract surgery].
Hessemer V; Schmitt K; Jacobi A
Klin Monbl Augenheilkd; 1996 Mar; 208(3):161-6. PubMed ID: 8699774
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation.
Sandoval HP; De Castro LE; Vroman DT; Solomon KD
J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of indomethacin 0.1% eye drops compared with ketorolac 0.5% eye drops in the management of ocular inflammation after cataract surgery.
Weber M; Kodjikian L; Kruse FE; Zagorski Z; Allaire CM
Acta Ophthalmol; 2013 Feb; 91(1):e15-21. PubMed ID: 22970738
[TBL] [Abstract][Full Text] [Related]
14. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients.
Wittpenn JR; Silverstein S; Heier J; Kenyon KR; Hunkeler JD; Earl M;
Am J Ophthalmol; 2008 Oct; 146(4):554-560. PubMed ID: 18599019
[TBL] [Abstract][Full Text] [Related]
15. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation.
Tan DT; Chee SP; Lim L; Lim AS
Ophthalmology; 1999 Feb; 106(2):223-31. PubMed ID: 9951469
[TBL] [Abstract][Full Text] [Related]
16. A single intraoperative sub-Tenon's capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation.
Paganelli F; Cardillo JA; Melo LA; Oliveira AG; Skaf M; Costa RA;
Ophthalmology; 2004 Nov; 111(11):2102-8. PubMed ID: 15522378
[TBL] [Abstract][Full Text] [Related]
17. Single perioperative subconjunctival steroid depot versus postoperative steroid eyedrops to prevent intraocular inflammation and macular edema after cataract surgery.
Dieleman M; Wubbels RJ; van Kooten-Noordzij M; de Waard PW
J Cataract Refract Surg; 2011 Sep; 37(9):1589-97. PubMed ID: 21855759
[TBL] [Abstract][Full Text] [Related]
18. A comparison of two different formulations of diclofenac sodium 0.1% in the treatment of inflammation following cataract-intraocular lens surgery.
Mester U; Lohmann C; Pleyer U; Steinkamp G; Völcker E; Kruger H; Raj PS
Drugs R D; 2002; 3(3):143-51. PubMed ID: 12099157
[TBL] [Abstract][Full Text] [Related]
19. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
Duong HV; Westfield KC; Chalkley TH
J Cataract Refract Surg; 2007 Nov; 33(11):1925-9. PubMed ID: 17964399
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification.
Almeida DR; Khan Z; Xing L; Bakar SN; Rahim K; Urton T; El-Defrawy SR
J Cataract Refract Surg; 2012 Sep; 38(9):1537-43. PubMed ID: 22795976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
